期刊文献+

蛋白芯片技术筛选无精症患者精浆中标志蛋白质

Screening of Seminal Plasma Biomarkers in Azoospermatism by SELDI Technique
下载PDF
导出
摘要 目的:利用蛋白质芯片和生物信息学方法从无精症患者精浆中筛选标志蛋白质。方法:采用表面增强激光解吸电离飞行时间质谱技术(SELDI-TOF-MS)和IMAC3蛋白质芯片对30例无精症患者精浆和57例健康人精浆的蛋白质谱图进行了检测,使用PBSⅡ-C型蛋白质芯片阅读机读取数据,获得的结果采用CI-PHERGEN公司的Biomarkerwizard和BiomarkerPatternsSystem软件分析。结果:无精症患者与正常人精浆蛋白质谱相比有16个显著差异蛋白质,其中6个蛋白质在患者精浆中高表达,10个蛋白质在患者精浆中低表达。BiomarkerPatternsSystem软件用16个显著差异蛋白质中的3个标志分子建立无精症诊断的分类树模型。检测灵敏度为86.7%(26/30)、特异性为96.5%(55/57)。结论:实验证明利用蛋白质组学和生物信息学方法可以从精浆中筛选出无精症相关的标志蛋白质,而且蛋白质芯片技术对于发现和筛选精浆中的无精症标志蛋白质是一种有效、快速的工具。 Objective To screen seminal plasma protern biomarkers in patients with azoospermatism with surface -enhanced laser desorpfion and ionization time of flight mass spectrometry ( SELDI - TOF - MS) technique. Methods Proteomic spectra of semina plasma were generated with mass spectrometry in 30 cases of azoospermatism and 57 controls and an algorithm for diagnosis was developed. Results A total of 16 distinguished different proteomic peaks were detected in the seminal plasma of the patients. Three peaks, one overexprossed and two underexpressed, were used to build a proteomic pattern algorithm for diagnosis. The results yielded a sensitivity of 86.7% (26/30) and specificity of 96.5 % (55/57). Conclusion SELDI - TOF - MS offers a unique platform for detection of azoospermia with proteomic spectrum. The method is accurate and can be performed rapidly for mass screening.
出处 《放射免疫学杂志》 CAS 2009年第1期89-91,共3页 Journal of Radioimmanology
基金 浙江省台州市科技局资助项目(061KY53)
关键词 芯片分析技术 无精症 蛋白质 microchip analytical procedures, azoospermatism, protein
  • 相关文献

参考文献6

二级参考文献28

  • 1粱勇,潘春琴,杨林军,刘池波,孙灵芬,朱雄文,张日初,张瑾,许洋,郭军华.血清蛋白质指纹图谱模型在胃腺癌诊断中的应用[J].中华检验医学杂志,2004,27(9):576-577. 被引量:18
  • 2Petricoin EF,Ardekani AM,Hitt BA,et al.Use of proteomic patterns in serum to identify ovarian cancer.Lancet,2002,359:572-577.
  • 3Li J,Zhang Z,Rosenzweig J,et al.Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.Clin Chem,2002,48:1296-1304.
  • 4金懋林,胃癌,内科肿瘤学[M].北京:人民卫生出版社,2001:549
  • 5Adam BL,Qu Y,Davis JW,Ward MD,Clements MA,Cazares LH,Semmes OJ,Schellhammer PF,Yasui Y,Feng Z,Wright GL Jr.Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.Cancer Res 2002; 62:3609-3614
  • 6Weinberger SR,Boschetti E,Santambien P,Brenac V.Surface-enhanced laser desorptionionization retentate chromatography mass spectrometry (SELDI-RC-MS):a new method for rapid development of process chromatography conditions.J Chromatogr B Analyt Technol Biomed Life Sci 2002; 782:307-316
  • 7Zhang L,Yu W,He T,Yu J,Caffrey RE,Dalmasso EA,Fu S,Pham T,Mei J,Ho JJ,Zhang W,Lopez P,Ho DD.Contribution of human alpha-defensin 1,2,and 3 to the anti-HIV-1 activity of CD8 antiviral factor.Science 2002; 298:995-1000
  • 8Bane TK,LeBlanc JF,Lee TD,Riggs AD.DNA affinity capture and protein profiling by SELDITOF mass spectrometry:effect of DNA methylation.Nucleic Acids Res 2002; 30:e69
  • 9Bandera CA,Ye B,Mok SC.New technologies for the identification of markers for early detection of ovarian cancer.Curr Opin Obstet Gynecol 2003; 15:51-55
  • 10Paweletz CP,Trock B,Pennanen M,Tsangaris T,Magnant C,Liotta LA,Petricoin EF 3rd.Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF:potential for new biomarkers to aid in the diagnosis of breast cancer.Dis Markers 2001; 17:301-307

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部